Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
Imidazolopiperazines (IZPs) are a class of compounds under clinical development for malaria, but their mechanism of action is unclear. Here, the authors show that IZPs inhibit the parasite’s secretory pathway, affecting protein trafficking and export.
Main Authors: | Gregory M. LaMonte, Frances Rocamora, Danushka S. Marapana, Nina F. Gnädig, Sabine Ottilie, Madeline R. Luth, Tilla S. Worgall, Gregory M. Goldgof, Roxanne Mohunlal, T. R. Santha Kumar, Jennifer K. Thompson, Edgar Vigil, Jennifer Yang, Dylan Hutson, Trevor Johnson, Jianbo Huang, Roy M. Williams, Bing Yu Zou, Andrea L. Cheung, Prianka Kumar, Timothy J. Egan, Marcus C. S. Lee, Dionicio Siegel, Alan F. Cowman, David A. Fidock, Elizabeth A. Winzeler |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15440-4 |
Similar Items
-
Quantitative structure–activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks
by: Saeed Yousefinejad, et al.
Published: (2019-09-01) -
Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling
by: Hiroko Hamai, et al.
Published: (2009-06-01) -
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
by: Claudia Tapia-Alveal, et al.
Published: (2020-12-01) -
Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.
by: Yaqin Xu, et al.
Published: (2010-06-01) -
A metallomic, proteomic and lipidomic investigation of the malaria parasites digestive vacuole and insights into the mediators of haemozoin formation
by: Mohunlal, Roxanne
Published: (2020)